Karyopharm Therapeutics | KPTI - 贸易债权人



金融业
股票价格
USD
资产
USD 108.42M
现金及等价物
USD 60.54M
销售成本
USD 1.48M
流动资产
USD 103.15M
流动负债
USD 92.06M
债务
USD 299.23M
股息收益率
0
EBIT
USD -17.84M
EBITDA
USD -26.2M
员工
325
EPS每股收益
USD -2.22
股本和储备
USD -292.93M
销售毛利
USD 32.6M
债务利息支出
USD 12.62M
利息收入
USD -0.15
贷款资金
USD 278.22M
市值
USD 1.07B
净收入
USD -102.2M
营业费用
USD 51.92M
营业利润
USD -17.84M
普通股股本
USD 18.31M
税前利润
USD -39.9M
销售收入
USD 34.08M
销售和管理费用
USD 9.56M
股票
USD 4.04M
贸易债权人
USD 4M
应收帐款人
USD 26.18M


贸易债权人 更改 日
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.24B 117M 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Incyte USD 228.62M 1.41B 2026-03
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Merck USD 3.86B 541M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.46B 99M 2025-12
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Takeda JPY 467.59B 28.61B 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 31M 9.57M 2025-12
Xencor USD 10.83M 1.75M 2025-12